Severe sepsis: variation in resource and therapeutic modality use among academic centers - Wikidata - awgldk - TriplyDB

Severe sepsis: variation in resource and therapeutic modality use among academic centers

Severe sepsis: variation in resource and therapeutic modality use among academic centers

http://www.wikidata.org/entity/Q24794938

about

A German national prevalence study on the cost of intensive care: an evaluation from 51 intensive care units Variation in sepsis care: a wake-up call Brazilian Sepsis Epidemiological Study (BASES study)Epidemiology of the Systemic Inflammatory Response Syndrome (SIRS) in the emergency department.Febrile neutropenia in French emergency departments: results of a prospective multicentre survey Results from the National Sepsis Practice Survey: use of drotrecogin α (activated) and other therapeutic decisions.Effect of Weekend Admissions on the Treatment Process and Outcomes of Internal Medicine Patients: A Nationwide Cross-Sectional Study.Timing of adequate antibiotic therapy is a greater determinant of outcome than are TNF and IL-10 polymorphisms in patients with sepsis.Temporal Changes in the Influence of Hospitals and Regional Healthcare Networks on Severe Sepsis Mortality.Diagnosis and treatment of severe sepsis.The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis.A new Elixhauser-based comorbidity summary measure to predict in-hospital mortality.Association of early withdrawal of life-sustaining therapy for perceived neurological prognosis with mortality after cardiac arrest.Are clinical trials dealing with severe infection fitting routine practices? Insights from a large registry.Incidence and outcome of sepsis in Japanese intensive care units: The Japanese nosocomial infection surveillance system.Charlson Index is associated with one-year mortality in emergency department patients with suspected infection.Economic evaluation in critical care: a focus on severe sepsis in oncology.Rapid real-time nucleic Acid sequence-based amplification-molecular beacon platform to detect fungal and bacterial bloodstream infections.

P2860

Q21195030-D0CE5FF9-68C7-4FDA-9838-633FB4BDA39E Q24795179-BC4B4219-3538-4ABD-8515-4FF0A0ED6839 Q24801014-3AC6CF47-7235-4656-BFC8-4F420EF48AE7 Q33629773-43154693-C976-48DD-B8AF-2E3DB0733867 Q33919284-D900790E-9CE4-425F-AEBC-E1EDACC16114 Q34297740-2098D147-A064-422A-8A67-3DA224793101 Q34513856-15B0934D-E5BE-4133-B5D2-945C3E9B8686 Q35544626-B00169AC-360A-482B-A35F-D8C712A798C9 Q35752122-4D367199-A3A7-4D89-A4D5-5DE0ADB71942 Q36438852-C4101999-2763-4E81-BB76-C989846173DC Q36467579-CDC55E29-6539-45B9-9564-316660D5042A Q36743028-F2704358-5FC1-4D73-A189-0899AF19454B Q36805535-33621BE6-6A26-4CA2-9CEF-337DE67D0430 Q36998459-F3C88522-6217-476E-BE6F-70C6B2C5D398 Q37296259-3458AF9D-E9F0-4090-A8C3-193DB5E38B77 Q39749300-BB2127C9-B90C-4C3A-89A4-D6089D046B97 Q40354685-96354A5B-BA8C-4FB8-9182-673BDADEDD5F Q43097224-AC11A852-D7FE-4504-B6F9-C95EE0908C30

P2860

Severe sepsis: variation in resource and therapeutic modality use among academic centers

http://www.wikidata.org/entity/Q24794938

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Severe sepsis: variation in resource and therapeutic modality use among academic centers

@ast

Severe sepsis: variation in resource and therapeutic modality use among academic centers

@en

Severe sepsis: variation in resource and therapeutic modality use among academic centers

@nl

type

label

Severe sepsis: variation in resource and therapeutic modality use among academic centers

@ast

Severe sepsis: variation in resource and therapeutic modality use among academic centers

@en

Severe sepsis: variation in resource and therapeutic modality use among academic centers

@nl

prefLabel

Severe sepsis: variation in resource and therapeutic modality use among academic centers

@ast

Severe sepsis: variation in resource and therapeutic modality use among academic centers

@en

Severe sepsis: variation in resource and therapeutic modality use among academic centers

@nl

P1433

Q24794938-B20A3BC4-5EC3-439B-A1B6-E75B07E58C67

P1476

Q24794938-D3169FEE-DA25-43BF-A002-077AFB5FDDE7

P2093

Q24794938-13752B9E-457A-4DC6-BB63-62CD1F8CAE36

Q24794938-199F7EF2-5E4D-4221-AFFA-8A69CA1B93A3

Q24794938-1A96FA9C-BA06-4436-85A0-198E9725FA53

Q24794938-4A7E39FA-C643-4AA3-A62F-AD2863637AB8

Q24794938-4DF598D4-43BA-4559-9602-4BFE8D2097E8

Q24794938-6C0A3760-3311-4077-8C59-B3E7AA341FD3

Q24794938-7330E558-FADA-476D-A430-DF57A48052A9

Q24794938-79D3A2A8-EBEE-4D6D-B856-C17072B5B112

Q24794938-80EEB96F-3B69-4A97-9019-891E7B1153C6

Q24794938-9AB9DBA4-43D4-44DB-A98B-00183FE1411F

P2860

Q24794938-02EF327B-E17B-4A0F-9859-6A0162B1D550

Q24794938-035A1776-3FF3-47DD-80BD-A049D74906CC

Q24794938-14460E26-153D-4035-BE71-0917C875D5AE

Q24794938-16A185AB-1786-4590-B8C0-5C8F6EBA81C2

Q24794938-1ADD5032-8060-4ABF-AB40-D32F8308A97F

Q24794938-259F8165-4A0D-4E44-9A11-92483636CCF1

Q24794938-2851A30C-62DD-4782-8244-3F129024F8F6

Q24794938-3691CD7D-51A0-437E-9AEF-9CD2BE96CDD0

Q24794938-3A1110C3-81ED-4B8A-8EF7-96C77855FF43

Q24794938-46599DD3-A131-4F9E-AAE4-B6D879A949A2

P2888

Q24794938-D605D7CF-0B6B-4C42-A54B-5E2650C34D45

P304

Q24794938-DB34820D-EC1D-4B2E-ABD6-54923DD4C6EC

P31

Q24794938-895DF30E-9676-4E91-8208-5084E40519F4

P356

Q24794938-C5651F3D-F3D6-462C-9AA4-2E743A795AFB

P407

Q24794938-79BD7918-16A8-453C-8E49-0550AE94D098

P433

Q24794938-FF89A392-B962-4BA7-9C83-B291E40A5F07

P478

Q24794938-044FCDF0-86F6-42F8-90A4-6C7A39709FD7

P50

Q24794938-70766163-521E-4F6B-9F46-13603C608D87

P577

Q24794938-3BCF6435-1FDE-4106-817F-E0B51083C343

P5875

Q24794938-7626F99F-E7EC-4579-8DD1-ECAC7BABA0DB

P6179

Q24794938-7105C011-04E7-475E-A0E8-FDDEDF86A382

P698

Q24794938-968F820A-EF13-4A59-B5F6-30F1F05781E8

P921

Q24794938-F7D33EDA-803E-4B6B-B936-6D85DC67FC0B

P932

Q24794938-DEEA85EF-CE51-4ECF-9AC1-8305407177B3

P356

P1433

P1476

Severe sepsis: variation in resource and therapeutic modality use among academic centers

@en

P2093

Academic Medical Center Consortium Sepsis Project Working Group

http://www.w3.org/2001/XMLSchema#string

D Tony Yu

http://www.w3.org/2001/XMLSchema#string

David W Bates

http://www.w3.org/2001/XMLSchema#string

Edgar Black

http://www.w3.org/2001/XMLSchema#string

J Sanford Schwartz

http://www.w3.org/2001/XMLSchema#string

Jeffrey Parsonnet

http://www.w3.org/2001/XMLSchema#string

Katherine L Kahn

http://www.w3.org/2001/XMLSchema#string

Kenneth E Sands

http://www.w3.org/2001/XMLSchema#string

Patricia L Hibberd

http://www.w3.org/2001/XMLSchema#string

Paul N Lanken

http://www.w3.org/2001/XMLSchema#string

P2860

The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is norepinephrine rather than dopamine

The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is dopamine rather than norepinephrine

Early goal-directed therapy in the treatment of severe sepsis and septic shock

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.

Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials.

Human albumin administration in critically ill patients: systematic review of randomised controlled trials.

Haemodynamic management of a patient with septic shock.

How promptly are inpatients treated for critical laboratory results?

P2888

P304

R24-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/CC2171

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

David R. Snydman

P577

2003-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10719102

http://www.w3.org/2001/XMLSchema#string

P6179

1040280884

http://www.w3.org/2001/XMLSchema#string

P698

12793887

http://www.w3.org/2001/XMLSchema#string

P921

P932

270675

http://www.w3.org/2001/XMLSchema#string